within Pharmacolibrary.Drugs.ATC.N;

model N05CA06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 3.9999999999999996e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00054,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0038333333333333336,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N05CA06</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Secobarbital is a short-acting barbiturate formerly used for the treatment of insomnia and as a preoperative sedative. It has also been used as an anticonvulsant in certain circumstances. Due to the significant risk of dependence, overdose, and the availability of safer alternatives, its use has become rare and is discontinued or highly restricted in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Lu, DR, &amp; Mao, F (1993). An interactive program for pharmacokinetic modeling. <i>Journal of pharmaceutical sciences</i> 82(5) 537–542. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600820521&quot;>10.1002/jps.2600820521</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8360833/&quot;>https://pubmed.ncbi.nlm.nih.gov/8360833</a></p></li><li><p>Chan, E, et al., &amp; Rowland, M (1994). Stereochemical aspects of warfarin drug interactions: use of a combined pharmacokinetic-pharmacodynamic model. <i>Clinical pharmacology and therapeutics</i> 56(3) 286–294. DOI:<a href=&quot;https://doi.org/10.1038/clpt.1994.139&quot;>10.1038/clpt.1994.139</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7924124/&quot;>https://pubmed.ncbi.nlm.nih.gov/7924124</a></p></li><li><p>Yih, TD, &amp; Rossum, JM (1976). Peculiar pharmacokinetics of brallobarbital as a source of complications in Vesparax intoxication. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 6(6) 355–362. DOI:<a href=&quot;https://doi.org/10.3109/00498257609151647&quot;>10.3109/00498257609151647</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/969563/&quot;>https://pubmed.ncbi.nlm.nih.gov/969563</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N05CA06;
